Armistice Capital’s Esperion Therapeutics ESPR Stock Holding History

Armistice Capital’s Portfolio ESPR Stock Details ESPR Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.8M	Buy
2024 Q1	–	Sell
2023 Q4	$9.57M	Buy
2023 Q3	–	Sell
2023 Q2	$12.8M	Buy
2023 Q1	$5.85M	Buy